Boothbay Fund Management »

Lipocine shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $441k 55k 8.03

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Lipocine

Diadema Partners
Vanguard Group
Ikarian Capital
BlackRock
Persistent Asset Partners
Geode Capital Management
Boothbay Fund Management
Renaissance Technologies
Susquehanna International
State Street Corporation
Ameriprise Financial
Citadel Advisors
Northern Trust
Dimensional Fund Advisors
Jane Street

View all funds holding Lipocine